These assets included ImaRx ' remaining Urokinase inventory as well as the regulatory file for the product ( formerly known as Abbokinase ( R ) , now rebranded as Kinlytic ( R ) ) , key raw materials for Urokinase manufacture , and the corresponding sales and marketing infrastructure .